Page last updated: 2024-09-04

2,3-bis(palmitoyloxy)-2-propyl-1-palmitoylcysteine and Crohn Disease

2,3-bis(palmitoyloxy)-2-propyl-1-palmitoylcysteine has been researched along with Crohn Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adema, GJ; de Jong, DJ; Drenth, JP; Ferwerda, G; Girardin, SE; Jacobs, L; Jansen, T; Kramer, M; Kullberg, BJ; Naber, TH; Netea, MG; Van der Meer, JW1

Other Studies

1 other study(ies) available for 2,3-bis(palmitoyloxy)-2-propyl-1-palmitoylcysteine and Crohn Disease

ArticleYear
Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release.
    Journal of immunology (Baltimore, Md. : 1950), 2005, May-15, Volume: 174, Issue:10

    Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Cells, Cultured; Crohn Disease; Cysteine; Cytokines; Drug Synergism; Humans; Intracellular Signaling Peptides and Proteins; Lipopeptides; Lipoproteins; Macrophages, Peritoneal; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Mycoplasma; Nod2 Signaling Adaptor Protein; Oligopeptides; Peptidoglycan; Receptors, Cell Surface; Receptors, Immunologic; Signal Transduction; Toll-Like Receptor 2; Toll-Like Receptor 3; Toll-Like Receptor 4; Toll-Like Receptor 5; Toll-Like Receptor 7; Toll-Like Receptor 9; Toll-Like Receptors

2005